9D9 is a frequently applied CTLA-4-blocking agent for immunological investigations, particularly relating to malignancy treatment. First , developed for blocking CTLA-4 capability, 9D9 efficiently https://www.targetmol.com/compound/anti_mouse_ctla_4_antibody_9d9